Research graph
References from The Challenges of Perioperative Anaphylaxis. Local targets link to admitted publications; unresolved targets remain external evidence.
Anaphylaxis: A 2023 practice parameter update
10.1016/j.anai.2023.09.015 · 2024 · External reference
Unresolved reference
External reference
10.1016/j.iac.2026.01.007
10.1016/j.iac.2026.01.007 · External reference
Anaphylaxis definition, overview, and clinical support tool: 2024 consensus report-a GA(2)LEN project
10.1016/j.jaci.2025.01.021 · 2025 · External reference
Groupe d'Etudes des Reactions Anaphylactoides P. Anaphylaxis during anesthesia in France: an 8-year national survey
10.1016/j.jaci.2011.03.003 · 2011 · External reference
World Allergy Organization anaphylaxis guidance 2020
10.1016/j.waojou.2020.100472 · 2020 · External reference
Time to revisit the definition and clinical criteria for anaphylaxis?
10.1016/j.waojou.2019.100066 · 2019 · External reference
NIAID-sponsored 2010 guidelines for managing food allergy: applications in the pediatric population
10.1542/peds.2011-0539 · 2011 · External reference
Anaphylaxis and anaphylactoid reactions. Classification and pathophysiology
10.1007/bf02737644 · 1999 · External reference
Epinephrine and anaphylaxis outcomes: Does timing matter?
10.1016/j.anai.2024.08.029 · 2024 · External reference
Drug Allergy Practice Parameter Updates to Incorporate Into Your Clinical Practice
10.1016/j.jaip.2022.12.002 · 2023 · External reference
Drug allergy: A 2022 practice parameter update
10.1016/j.jaci.2022.08.028 · 2022 · External reference
Outcome of repeat anaesthesia after investigation for perioperative anaphylaxis
10.1016/j.bja.2018.02.033 · 2018 · External reference
Perioperative Hypersensitivity Evaluation and Management: A Practical Approach
10.1016/j.jaip.2022.11.012 · 2023 · External reference
Practical Guidelines for Perioperative Hypersensitivity Reactions
10.18176/jiaci.0236 · 2018 · External reference
Practical guidelines for the response to perioperative anaphylaxis
10.1007/s00540-021-03005-8 · 2021 · External reference
Management of suspected immediate perioperative allergic reactions: an international overview and consensus recommendations
10.1016/j.bja.2019.04.044 · 2019 · External reference
Perioperative Allergic Reactions: Allergy Assessment and Subsequent Anesthesia
10.1016/j.jaip.2020.11.025 · 2021 · External reference
Organ failure type in fatal and near-fatal anaphylaxis: a systematic review
10.1136/bmjopen-2025-108996 · 2026 · External reference
Mechanism of Cardiac Arrest in Fatal Anaphylaxis
10.1111/cea.70289 · 2026 · External reference
Anaesthesia, surgery, and life-threatening allergic reactions: epidemiology and clinical features of perioperative anaphylaxis in the 6th National Audit Project (NAP6)
10.1016/j.bja.2018.04.014 · 2018 · External reference
Knowledge gaps in the diagnosis and management of anaphylaxis
10.1016/j.anai.2023.05.010 · 2023 · External reference
A US-Based Multicenter Retrospective Report of Perioperative Anaphylaxis, 2010-2021
10.1016/j.jaip.2024.02.042 · 2024 · External reference
Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis
10.1016/j.jaci.2021.08.007 · 2022 · External reference
Diagnosis and Management of Patients With Mast Cell Activation Syndromes: Status 2026
10.1016/j.jaip.2025.10.046 · 2026 · External reference
Nontryptase Urinary and Hematologic Biomarkers of Mast Cell Expansion and Mast Cell Activation: Status 2022
10.1016/j.jaip.2022.03.008 · 2022 · External reference
Comparison of Basophil Activation Test and Skin Testing Performances in NMBA Allergy
2018 · External reference
An emerging trigger of intraoperative anaphylaxis
10.1016/j.anai.2016.09.428 · 2016 · External reference
Anaphylaxis Induced by Rocuronium, Sugammadex, or Rocuronium-Sugammadex Complex: Summary of Published Cases
10.1213/ane.0000000000008024 · 2026 · External reference
Sugammadex Anaphylaxis: Mechanisms, Diagnosis, and Incidence
10.1097/aln.0000000000005431 · 2025 · External reference
Sugammadex-Associated Anaphylaxis: Summary and Proposed Management
10.1213/ane.0000000000006759 · 2024 · External reference
Sugammadex-Associated Anaphylaxis
10.1213/ane.0000000000007112 · 2024 · External reference
Rocuronium-specific antibodies drive perioperative anaphylaxis but can also function as reversal agents in preclinical models
10.1126/scitranslmed.ado4463 · 2024 · External reference
Peri-operative management of neuromuscular blockade: A guideline from the European Society of Anaesthesiology and Intensive Care
10.1097/eja.0000000000001769 · 2023 · External reference
Empty mast cell syndrome: fallacy or fact?
10.1136/jclinpath-2019-206157 · 2020 · External reference
Reliability of Early and Late Testing for Suspected Perioperative Hypersensitivity
10.1016/j.jaip.2021.10.066 · 2022 · External reference
Bruton's tyrosine kinase inhibition for the prevention of anaphylaxis: an open-label, phase 2 trial
2023 · External reference
A phase II study of Bruton's tyrosine kinase inhibition for the prevention of anaphylaxis
2023 · External reference
Severe anaphylactic shock due to ethylene oxide in a patient with myelomeningocele: successful exposure prevention and pretreatment with omalizumab
10.1097/acc.0b013e3182a08ff1 · 2014 · External reference
